About the Authors

Tobias Meischl

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Susanne Rasoul-Rockenschaub

Roles Writing – review & editing

Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria

Georg Györi

Roles Writing – review & editing

Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria

Wolfgang Sieghart

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Thomas Reiberger

Roles Writing – review & editing

Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria

Michael Trauner

Roles Supervision, Writing – review & editing

Affiliation Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria

Thomas Soliman

Roles Writing – review & editing

Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria

Gabriela Berlakovich

Roles Writing – review & editing

Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria

Matthias Pinter

Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing

matthias.pinter@meduniwien.ac.at

Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Competing Interests

We have read the journal's policy and the authors of this manuscript have the following competing interests: T.M. declares no competing interests. S.R.-R. declares no competing interests. G.G. declares no competing interests. W.S. received speaker and consulting fees and research grants from Bayer Schering Pharma; he also served as consultant for Eisai, Lilly, and BMS. T.R. has received grant support from Abbvie, Boehringer-Ingelheim, Gilead, MSD, Philips Healthcare, Gore; speaking honoraria from Gilead, Gore, Intercept, Roche, MSD; consulting/advisory board fee from Abbvie, Boehringer-Ingelheim, Gilead, MSD; and travel support from Boehringer-Ingelheim, Gilead and Roche. M.T. served as speaker for BMS, Falk, Gilead, and MSD; advisory boards for Albireo, Falk, Genfit, Gilead, Intercept, MSD, Novartis, Phenex, and Regulus. He further received travel grants from Abbvie, Falk, Gilead, and Intercept, and unrestricted research grants from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda. He is also co-inventor of a patent on the medical use of norUDCA. T.S. declares no competing interests. G.B. has received grant support from Sandoz, Chiesi, MSD, Shire; speaking honoraria from Neovii, Chiesi, Astellas; consulting/advisory board fee from Astellas, Neovii, Chiesi, Sanofi; and travel support from Astellas, Chiesi, Neovii, Biotest. M.P. served as consultant for Bayer, BMS, Eisai, and Ipsen, and received travel support from Bayer and speaking fees from Bayer and BMS. He is also an investigator for Bayer, BMS and Lilly. This does not alter our adherence to PLOS ONE policies on sharing data and materials.